Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Hematology
Description:
Welcome to the podcast. Today, we’re exploring the key signs and symptoms of leukemia, a type of blood cancer. Leukemia often begins with symptoms that can be easily overlooked, such as persistent fatigue and frequent infections. You might also notice unexplained bruising or bleeding, small red spots on the skin known as petechiae, or swollen lymph nodes. Some people experience bone or joint pain, night sweats, or unintentional weight loss. While these symptoms might be caused by less serious conditions, it’s important to consult a healthcare professional if they persist. Early detection of leukemia can make a significant difference in treatment outcomes. Stay informed and take care of your health.
See More Webinars @ Hidoc Webinars
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study
3.
It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.
4.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
5.
Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.
1.
Emerging Advances in Hematology and Quality Improvement
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Nuclear Medicine's Role in Battling Women's Cancers
4.
Genetic Screening: A Game Changer in Cancer Prevention
5.
Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part VII
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
3.
Signs and Symptoms of Leukemia
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge